Experience

CaviSense

• United States
• Medical Device
• 1 - 100 Employee

• Chief Executive Officer

  • Jun 2023 - Present

  Greater Boston Cavisense has developed a proprietary technology able to identify cavities quickly, accurately and cost effectively from anywhere



Xtrodes Ltd

• Chief Commercial Officer (CCO)

  • Jan 2022 - May 2023

  Tel Aviv, Israel o Commercial activities – “The first dry printed medical grade electrodes” o Generated meaningful sales in first year of commercialization o Strategic projects with leading industry players in several fields o Initiated clinical studies and projects at Johns Hopkins, Mayo Clinic, Harvard, U Michigan o Strategic partnerships and discussions with electrophysiology companies o Built GoToMarket strategy for Sleep indication



Pulsenmore Ltd

• Chief Commercial Officer

  • Jun 2020 - Jan 2022

  o Successful TASE IPO in June 2021 at $250M raising $60M o Sales of 20,000+ units in Israel with Clalit and Maccabi o Direct sales teams in Germany and France generated commercial pilots and partnerships with private hospitals o Agreement with distributor in Italy and numerous discussions with strategic partners o Commercial pilot studies in Dubai, Turkey, Chile, Poland, Thailand and a robust pipeline of interested distributors in 15 countries o Built company communication… Show more o Successful TASE IPO in June 2021 at $250M raising $60M o Sales of 20,000+ units in Israel with Clalit and Maccabi o Direct sales teams in Germany and France generated commercial pilots and partnerships with private hospitals o Agreement with distributor in Italy and numerous discussions with strategic partners o Commercial pilot studies in Dubai, Turkey, Chile, Poland, Thailand and a robust pipeline of interested distributors in 15 countries o Built company communication platform: Logo, website, press releases, marketing presentations Show less



Regenera Pharma

• Israel
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Chief Executive Officer

  • Jul 2017 - Oct 2020

  Israel Clinical Activities o Phase 2/3 clinical study in NAION (Stroke of Optic Nerve), recruited 150 patients in 14 centers in the US o Phase 2 study in 82 Alzheimer’s patients in 5 centers in Canada R&D activities o Large preclinical MCAO rat stroke study at Detroit Henry Ford Center, large PD mutated mouse study at Tufts Medical Center and Aged dog cognition study at University of Wisconsin, Madison o Multiple In Vitro studies to delineate mechanism of Action o CMC: GMP batch… Show more Clinical Activities o Phase 2/3 clinical study in NAION (Stroke of Optic Nerve), recruited 150 patients in 14 centers in the US o Phase 2 study in 82 Alzheimer’s patients in 5 centers in Canada R&D activities o Large preclinical MCAO rat stroke study at Detroit Henry Ford Center, large PD mutated mouse study at Tufts Medical Center and Aged dog cognition study at University of Wisconsin, Madison o Multiple In Vitro studies to delineate mechanism of Action o CMC: GMP batch production and potency assay development Regulatory o Approval of clinical studies and Fast Track designation from FDA Management/Leadership: 10 senior employees across disciplines Financial o Raised $30M from multiple sources with aMoon Fund as lead o Worked with investment banks and interfaced with Pharma to explore strategic partnerships Show less



Champions Oncology, Inc.

• United States
• Biotechnology
• 100 - 200 Employee

• Chief Commercial Officer

  • Nov 2010 - Jun 2017

  General Manager of Global Personalized Oncology Business and Global Translational Oncology Business o Responsible for $20M in annual sales and two global businesses o Led international teams: sales, marketing, and business support o Directed a global leading CRO serving Pharma and Biotech companies. Help guide their oncology drug development through design and execution of PDX studies o Helped establish PDX as the gold standard in oncology drug development modeling o Introduced… Show more General Manager of Global Personalized Oncology Business and Global Translational Oncology Business o Responsible for $20M in annual sales and two global businesses o Led international teams: sales, marketing, and business support o Directed a global leading CRO serving Pharma and Biotech companies. Help guide their oncology drug development through design and execution of PDX studies o Helped establish PDX as the gold standard in oncology drug development modeling o Introduced pioneering PDX service offerings in AML, Immuno-Oncology and Clinical Trial settings o Grew market and market share in key geographic areas o Pioneered commercialization of PDX for clinical use o Served over 1,000 cancer patients and hundreds of oncologists to guide patient treatment based on PDX study results o Established 8 implantation centers and business operations in 5 countries on 4 continents o Established Partnerships with the Mayo clinic, Cedars Sinai Hosp, Mt Sinai New York, University of Florida, Marsden (London), Parkway Cancer Center (Singapore), Sheba (Israel) etc. Show less



Polyheal Ltd

• United Kingdom
• Construction

• CEO

  • Aug 2008 - Dec 2010

  Israel Achieved an exit with a global pharma company valued at $90M from a beginning valuation of $10M in 2008 Achieved key product and company milestones: o Raised $4M during financial crisis o Received CE mark EU marketing approval for lead product o Executed two successful clinical trials including a multi-center RCT and EU post marketing surveillance study o Developed strong KOL support in EU and US o Manufactured multiple lots and passed multiple inspections


Pfizer Pharmaceuticals
• Australia
• Executive Offices
• Marketing Director Pfizer Israel

  • 2005 - 2008


Glaxo Smith Kline Pharmaceuticals - France

• Regional Sales Director - Global Ex Pat Assignment

  • 2003 - 2005

  Paris, France Managed 100 sales people in the CNS division for the Western third of France



Glaxo Smith Kline Pharmaceuticals - U.S.A

• Sr Product Manager - Infanrix, Twinrix Vaccines

  • 1998 - 2003

  Philadelphia, PA



Sanofi Pasteur

• Pharmaceutical Manufacturing
• 200 - 300 Employee

• Global Management Development Program

  • 1994 - 1998

  U.S, France, and Canada Assignments in Sales (U.S), Strategy (France) and Manufacturing (Canada)